Physician profile
Nathan Lawrence
NPI 1346624327
$2,918.25
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $689 · 2021: $1,812 · 2022: $32.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $471.11 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $305.47 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $257.67 | 2020-2021 | |
| Abbvie INC. | $248.18 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $220.31 | 2020-2021 | |
| Amgen INC. | $186.56 | 2021 | |
| Tanabe Pharma America, INC. | $145.20 | 2019-2021 | |
| Ucb, INC. | $136.48 | 2020-2021 | |
| Lilly USA, LLC | $115.25 | 2020-2021 | |
| Emd Serono, INC. | $101.12 | 2021 | |
| Sk Life Science, INC. | $87.76 | 2021 | |
| Csl Behring | $83.86 | 2019-2021 | |
| Biogen, INC. | $66.46 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $60.05 | 2020-2021 | |
| Ipsen Biopharmaceuticals, INC | $54.39 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $40.58 | 2019-2020 | |
| Lundbeck LLC | $36.62 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $30.45 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Supernus Pharmaceuticals, INC. | $23.80 | 2021 | |
| Boston Scientific Corporation | $18.21 | 2022 | |
| Genentech USA, INC. | $18.11 | 2020 | |
| Eisai INC. | $17.18 | 2020 | |
| Sunovion Pharmaceuticals INC. | $16.57 | 2021 | |
| Grifols USA, LLC | $16.32 | 2021 | |
| Horizon Therapeutics Plc | $15.80 | 2021 | |
| Adamas Pharmaceuticals, INC. | $14.98 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.35 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $13.21 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.90 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.83 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.74 | 2021 | |
| Ge Healthcare | $11.70 | 2021 | |
| Assertio Therapeutics, INC. | $11.69 | 2020 | |
| Harmony Biosciences LLC | $11.58 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.